BioSpace News Archive

Policy

Mallinckrodt Plans Spin-Off of Specialty Generics Business to Shareholders

Transaction expected to create two differentiated pharmaceutical companies with scale - One focused on innovative specialty pharmaceutical brands; One with a portfolio of niche specialty generic products, active pharmaceutical ingredients (APIs), and non-promoted brands including the AMITIZA® product

December 6, 2018
·
14 min read
Genetown

Ascend Wellness Closes $40M Funding Round

Company plans to become leading cannabis operator in Massachusetts, Michigan and Illinois markets

December 6, 2018
·
2 min read
Business

Knopp Biosciences Appoints Mark Kreston as Chief Commercial Officer

30-year Industry Veteran Will Lead Knopp’s Global Commercialization, Business Development Functions as Company Advances Lead Asset into Late Stage Clinical Development

December 6, 2018
·
4 min read
Pharm Country

MYOS RENS Technology Announces Approval of $1.2 Million in NJEDA NOL Program Tax Credits

Net Proceeds of $1.1 Million in Non-dilutive Funding Expected

December 6, 2018
·
3 min read
Policy

/R E P E A T -- Media Advisory - Government of Canada to announce new research fund seeking bold ideas to shape health, environment, economy and communities/

The Honourable Kirsty Duncan, Minister of Science and Sport, will announce a new fund for researchers to pursue fast-breaking, high-risk and transformative research, leading to discoveries that will help change the world and better the lives of Canadians.

December 6, 2018
·
1 min read
Business

Emosis and Accellix Announce Intent to Form a Joint Venture, EmoCellix

EmoCellix will focus on marketing a complete solution for hemostasis cytomolecular diagnostics

December 6, 2018
·
2 min read
BioForest

Impel NeuroPharma Closes $67.5 Million Series D Financing

Crossover Financing to Advance Clinical Development of Central Nervous System Assets in Migraine, Parkinson’s Disease and Acute Agitation

December 6, 2018
·
3 min read
Genetown

Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention

CorPath® telerobotic interventional platform has the potential to deliver timely, specialized cardiovascular treatment to remote, underserved patient populations across the globe.

December 6, 2018
·
9 min read
Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting

Global Cord Blood Corporation today announced the results of its 2018 Annual General Meeting, which was held on December 5, 2018, in Hong Kong S.A.R., China.

December 6, 2018
·
2 min read
BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York

BioLineRx Ltd. announced today that it will host an investor breakfast meeting on Tuesday, December 11, 2018 at the Convene Conference Center near Grand Central Terminal in New York, N.Y.

December 6, 2018
·
6 min read